Literature DB >> 19279298

Randomized trial of presenting absolute v. relative risk reduction in the elicitation of patient values for heart disease prevention with conjoint analysis.

Jennifer M Griffith1, Carmen L Lewis, Sarah Hawley, Stacey L Sheridan, Michael P Pignone.   

Abstract

BACKGROUND: The authors performed a randomized controlled trial to test the effect of 2 different formats of risk reduction information when using conjoint analysis to elicit values about heart disease prevention.
METHODS: Participants ages 30 to 75 were enrolled and presented the same hypothetical scenario: a person with a 13% ten-year risk of heart disease. Participants then worked through a values elicitation exercise using conjoint analysis, making pairwise comparisons of hypothetical treatments that differed on 5 attributes. For the attribute "ability to reduce heart attacks," participants were randomized to receive either absolute risk reduction (ARR) or relative risk reduction (RRR) information. Participants selected which attribute they felt was most important. Participants' responses to the pairwise comparisons were then used to generate their most important attribute using ordinary least squares regression. Outcomes included differences between groups in the proportion choosing and generating ability to reduce heart attacks as the most important attribute.
RESULTS: In total, 113 participants completed the study: mean age was 51, 29% were male, 52% were white, and 42% were African American. The proportion who selected the ability to reduce heart attacks as the most important treatment attribute did not differ significantly (64% RRR; 53% ARR, Fisher's P=0.26). For the conjoint-generated most important attribute, those receiving the RRR version were significantly more likely to generate ability to reduce heart attacks as the most important attribute (59% RRR; 35% ARR, Fisher's P=0.01). DISCUSSION: Risk presentation format appears to affect the perceived value of different treatment attributes generated from conjoint analysis.

Entities:  

Mesh:

Year:  2009        PMID: 19279298     DOI: 10.1177/0272989X08327492

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  6 in total

Review 1.  Risk as an attribute in discrete choice experiments: a systematic review of the literature.

Authors:  Mark Harrison; Dan Rigby; Caroline Vass; Terry Flynn; Jordan Louviere; Katherine Payne
Journal:  Patient       Date:  2014       Impact factor: 3.883

2.  A comparison of two experimental design approaches in applying conjoint analysis in patient-centered outcomes research: a randomized trial.

Authors:  Elizabeth T Kinter; Thomas J Prior; Christopher I Carswell; John F P Bridges
Journal:  Patient       Date:  2012       Impact factor: 3.883

3.  Conjoint analysis versus rating and ranking for values elicitation and clarification in colorectal cancer screening.

Authors:  Michael P Pignone; Alison T Brenner; Sarah Hawley; Stacey L Sheridan; Carmen L Lewis; Daniel E Jonas; Kirsten Howard
Journal:  J Gen Intern Med       Date:  2011-08-26       Impact factor: 5.128

4.  What Matters to Women When Making Decisions About Breast Cancer Chemoprevention?

Authors:  Kathryn A Martinez; Angela Fagerlin; Holly O Witteman; Christine Holmberg; Sarah T Hawley
Journal:  Patient       Date:  2016-04       Impact factor: 3.883

5.  Understanding rational non-adherence to medications. A discrete choice experiment in a community sample in Australia.

Authors:  Tracey-Lea Laba; Jo-Anne Brien; Stephen Jan
Journal:  BMC Fam Pract       Date:  2012-06-20       Impact factor: 2.497

6.  Preferences of Patients and Pharmacists with Regard to the Management of Drug-Drug Interactions: A Choice-Based Conjoint Analysis.

Authors:  Mette Heringa; Annemieke Floor-Schreudering; Hans Wouters; Peter A G M De Smet; Marcel L Bouvy
Journal:  Drug Saf       Date:  2018-02       Impact factor: 5.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.